Zidovudine and Lamivudine Tablets

Product Description

Zidovudine, commonly known by its brand name Retrovir, is an antiretroviral medication used in the treatment of HIV (human immunodeficiency virus) infection. It belongs to a class of drugs called nucleoside reverse transcriptase inhibitors (NRTIs). Zidovudine works by inhibiting the activity of reverse transcriptase, an enzyme that HIV needs to replicate itself.

Here are some key points about Zidovudine tablets:

1. Indications: Zidovudine is used in combination with other antiretroviral medications to slow down the progression of HIV infection and reduce the risk of developing acquired immunodeficiency syndrome (AIDS).

2. Dosage: The dosage of Zidovudine can vary based on individual factors, including age, weight, and other health conditions. It is typically taken orally in the form of tablets.

3. Side Effects: Like any medication, Zidovudine may cause side effects. Common side effects include nausea, headache, fatigue, and changes in blood cell counts. It is essential to report any severe or persistent side effects to a healthcare provider.

4. Pregnancy and Breastfeeding: Zidovudine may be used during pregnancy to reduce the risk of mother-to-child transmission of HIV. It can also be excreted in breast milk, so its use during breastfeeding should be discussed with a healthcare provider.

5. Resistance: As with other antiretroviral drugs, there is a risk of developing resistance to Zidovudine if not taken as prescribed. It is crucial for individuals with HIV to take their medications consistently and follow their healthcare provider's instructions.

6. Monitoring: Regular monitoring of blood counts and other laboratory parameters is often recommended during Zidovudine treatment to assess its effectiveness and detect any potential side effects.

It's important to note that information on medications can change, and it is always advisable to consult with a healthcare professional or pharmacist for the most up-to-date and personalized information regarding the use of Zidovudine or any other medication

Dual Antiretroviral Action

Zidovudine and Lamivudine Tablets combine two effective NRTIs, offering a robust approach to suppressing HIV-1 replication. By targeting the virus at two different steps, the combination slows disease progression and helps in reducing viral loads, supporting patients to lead healthier lives with consistent therapy.


Designed for Compliance

With a fixed-dose formulation, these tablets improve convenience by reducing pill burden, supporting better adherence. The oval, film-coated design enhances swallowing for both adults and children, while choice of blister or HDPE bottle packaging maintains product stability and extends shelf life under proper storage conditions.